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ABSTRACT 
 
Background  
Optimal cancer care requires a multidisciplinary approach. The purpose of the 
current study was to evaluate the impact of a multidisciplinary tumor board on the 
treatment plans of children with solid tumors. 
Procedures 
  The records of 158 consecutive patients discussed at a formal multidisciplinary 
pediatric tumor board between July 2012 and April 2014 were reviewed. Treatment 
plans were based on clinical practice guidelines and on current Children’s Oncology 
Group protocols. Alterations in radiologic, pathologic, surgical, and medical 
interpretations were analyzed to determine the impact on changes in recommendations 
for clinical management.  
Results 
 Overall, 55 of 158 children (35%) had alterations in radiologic, pathologic, 
medical or surgical interpretation of clinical data following multidisciplinary discussion.  
Of these, 64% had changes to the initial recommendation for clinical management. 
Review of imaging studies resulted in interpretation changes in 30 of 158 patients 
studied (19%), with 12 clinical management changes. Six of 158 patients (3.9%) had 
changes in pathologic interpretation, with 4 patients (2.5%) requiring treatment 
changes. In 8 patients (5%), a change in medical management was recommended while 
in 11 patients (7%) there were changes in surgical management that were based solely 
on discussion and not on interpretation of imaging or pathology. 
Conclusions 
Formal multidisciplinary review led to alterations in interpretation of clinical 
data in 35% of patients, and the majority led to changes in recommendations for 
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treatment. Comprehensive multidisciplinary tumor board incorporated into the care of 
children with cancer provides additional perspectives for families and care providers 
when delineating optimal treatment plans. 
 
INTRODUCTION 
The contemporary care of pediatric cancer has become increasingly complex and 
specialized.  With the advent of multimodal therapies that span a broad spectrum of  
medical and surgical advancements, optimal therapeutic plans have become sub-
specialized in nature. Nearly all children diagnosed with cancer in the United States are 
managed based on protocols and standard-of-care set by the Children’s Oncology Group. 
The most successful survival outcomes are achieved by multidisciplinary treatment 
strategies that incorporate chemotherapy, surgery, radiation oncology, immunotherapy, 
and targeted therapy. Given this, there is increasing need for involvement of pediatric 
specialists in decisions made regarding diagnostic testing, biopsy technique, surgical 
resectability, chemotherapy regimen, and surveillance plans. To enhance 
communication and interaction among specialists, formal multidisciplinary tumor 
boards (MTB) and case conferences are utilized in many health care settings to 
formulate treatment plans. Although multidisciplinary care has become accepted as the 
optimal mechanism for delivering care in adult oncology, little qualitative or 
quantitative data exists to determine the impact of MTB on patient outcomes 1-4. The 
paucity of objective data is even more pronounced when examining pediatric MTB, as 
there are currently no standard requirements or recommendations for MTB review for 
children.  
At our institution, patients with solid tumors are diagnosed primarily or are 
referred for second opinion after initial diagnosis or suspicion of cancer. Cases are 
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discussed at a weekly MTB with 30-35 participants from pediatric subspecialties in 
oncology, surgery, diagnostic and interventional radiology, and pathology. Specialists in 
nuclear medicine, radiation oncology, adolescent gynecology, and cancer genetics are 
also present and participate in the weekly care conference. We sought to examine our 
own experience with children evaluated in this manner and to determine the impact of 
MTB on clinical management. 
 
MATERIALS AND METHODS 
 The records of 158 consecutive patients referred to pediatric MTB for discussion 
over a two-year time period between July 2012 and April 2014 were retrospectively 
reviewed. With approval of the Institutional Review Board, patient records were 
reviewed for changes in final radiologic, pathologic, medical, and surgical 
interpretations, and the effects these alterations had on clinical management. Patients 
with solid tumors were initially diagnosed at C.S Mott Children’s Hospital, Ann Arbor, 
MI, or referred for second opinion consultation from an outside institution. Referring 
physicians at outside institutions were provided the option of presenting their patients 
and joining into the tumor board discussion either in person or by teleconference. Brain 
tumors are a part of a separate tumor board and were not included in this pediatric 
MTB.  Patients with leukemia and lymphomas were included if there was a need for 
potential surgical intervention or multidisciplinary consensus on imaging or pathology 
(e.g. nodal status and biopsy, mass resection, lung lesions). Referral for discussion at 
pediatric MTB was then made by the initial evaluating service and medical records, 
imaging, histologic slides, and other diagnostic materials were forwarded for review. All 
imaging studies and reports were submitted to the pediatric diagnostic radiologists for 
interpretation and specimen slides were submitted to the pediatric pathologists. The list 
  
 
This article is protected by copyright. All rights reserved. 
 
5 
of tumor board patients for discussion at the weekly meeting was then sent out by email 
to all invited participants including pediatric oncologists, surgeons, radiologists, 
pathologists, interventional radiologists, and radiation oncologists prior to each 
meeting. There was interdepartmental commitment (pediatric oncology, surgery, 
radiology, and pathology) that at least one but ideally two to three consistent pediatric 
physician representatives from each specialty would participate in tumor board 
discussions each week. The entire multidisciplinary team then met in consultation to 
discuss each child. Team members present at MTB also included advanced practice 
nurses and physician assistants, dieticians, social workers, child-life specialists, and 
trainees from all disciplines. During the comprehensive meeting, the pertinent history, 
physical examination findings, diagnostic tests, and original plan for each patient were 
presented and outlined. Pertinent radiologic and pathologic studies were displayed and 
collectively discussed.  A consensus diagnosis, staging, and treatment plan was then 
agreed upon and carried forward.  Treatment plans were made based on current 
Children’s Oncology Group clinical trial protocols, literature review, and guidelines 
when available for each pediatric solid tumor. After review at tumor board, a detailed 
progress note entitled “Multidisciplinary Care Note” was placed in the patient’s chart, 
which included a summary of the discussion and any changes in interpretation of 
pathology or radiology.  Any official amendments of previous interpretations were 
made by the original interpreting physicians. Patients received resultant information 
from the involved physicians and the recommendations for treatment plans were 
shared either by clinic appointment or by phone conversation on the same day as the 
tumor board discussion. Patients were provided the opportunity for coordinated follow-
up appointments for surgery, chemotherapy, and radiation planning based on the 
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individualized treatment plans. Details of MTB findings and recommendations were 
documented and communicated back to referring physicians and outside institutions. 
 
RESULTS 
Review of Imaging 
Review of imaging at MTB resulted in changes in original interpretations in 30 of 
158 patients studied (19%).  Interestingly, nine of these changes (5.6%) in 
interpretation were in radiologic studies already previously reviewed at our institution.  
The most common change, found in 18 patients (11%) was the level of suspicion in a 
previously noted lesion. Twelve of these cases were a downgrade in the level of 
suspicion and thereby led to a consensus that there was no need for immediate 
intervention or therapy.  Five patients (3.1%) were recommended to undergo 
additional imaging to evaluate inconclusive lesions, and additional suspicious lesions 
were found in three patients (2%).  Two patients (1.2%) were recommended to 
undergo additional biopsies based on radiologic review, and in two patients (1.2%) the 
dominant lesion planned for biopsy was changed (Table 1).  Overall, in 12 of the 30 
cases (7.6%), in which there was a change in radiologic interpretation, there was a 
subsequent change in the clinical management that led to either a recommendation of 
observation (5%), change in staging (0.6%), change in the dominant lesion planned for 
biopsy or resection (1.2%), or plan for immediate operative intervention (0.6%) (Table 
1). 
 
Review of Pathology 
Review of pathologic specimen and histologic slides by tumor board participants 
resulted in changes in interpretation for 6 of 158 patients (3.8%) and confirmation of 
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diagnosis in 152/158.  Three patients (1.9%) had complete changes in their pathologic 
diagnosis, while three patients (1.9%) had an upgrade in stage of their disease (Table 
2).  These changes resulted in alterations in clinical management in four patients 
(2.5%), with one patient initiating chemotherapy, one patient changing chemotherapy 
protocol, one initiating radiation therapy, and one requiring further surgical resection 
(Table 2).  
 
Clinical Review by the Multidisciplinary Tumor Board 
In eight patients (5%), case review at tumor board led to changes in the 
recommended chemotherapeutic and medical management that were not based on 
changes in interpretation of radiologic or pathologic findings, but based primarily on 
multidisciplinary discussion and review of guidelines as interpreted by the medical, 
surgical, and radiation oncologists.  For three patients, this resulted in a continuation of 
the current chemotherapy regimen, while two patients were recommended initiation of 
a new cytotoxic regimen.  Cessation of chemotherapy was recommended in one patient 
and two patients were referred for surgical management rather than chemotherapy 
(Table 3). 
Similarly, case review at MTB led to changes in the recommended surgical 
management of 11 patients (7%), independent of changes in the interpretation of 
radiologic or pathologic findings.  For three patients, additional procedures including 
interventional radiology-based biopsy were recommended.  Changes in technical 
specifics of the operative plan were recommended in two patients.  In four patients, the 
original operative plan was not previously determined and was therefore confirmed 
and agreed upon based on MTB discussion.  Operative intervention was no longer 
recommended in two patients (Table 3). 
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Collectively, when alterations in analysis of diagnostic or clinical data (radiologic, 
pathologic, and clinical reviews) were combined, a total of 55 of 158 patients evaluated 
(35%) had changes in interpretation.  Significantly, of these, 35 patients (64%) had 
changes that resulted in a change in treatment or clinical management 
recommendations. 
 
DISCUSSION 
 MTBs are designed to enhance patient management and foster inter- and intra-
disciplinary discussion5.  MTBs allow specialists to work together to develop consensus 
recommendations in accordance with guidelines and protocols endorsed by the clinical 
team6.  Contemporary MTBs were first established in the United Kingdom following a 
landmark report published in 1995 that recommended that all cancer patients be 
assessed by surgeons who work with other specialists as part of a multidisciplinary 
team7.  Since then, mandates for multidisciplinary assessment in cancer care have been 
developed in Australia, Canada, and in the United States5.  The Commission on Cancer of 
the American College of Surgeons now makes MTB mandatory for accreditation of 
hospitals responsible for providing multidisciplinary cancer care8.  What remains 
unknown is the impact of MTBs on clinical management and patient outcomes. 
Review of multidisciplinary cancer care in the United Kingdom demonstrated 
that MTB improves communication, coordination, and decision-making between 
healthcare professionals when weighing treatment options9.   Several studies, however, 
have also demonstrated that poor organization, communication, and leadership often 
hinder MTB and actual clinical decision-making is a difficult and time-consuming 
process10-12.  Moreover, several studies have also demonstrated that there is 
variability in the implementation of MTB management decisions. 
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In terms of patient outcomes, a limited number of studies in adults have assessed 
the impact of MTBs17-19.  The common conclusion from these studies has been that 
MTB is associated with improved survival.  For example, a retrospective review of lung 
cancer patients found an improvement in median survival with the introduction of 
MTBs (3.2 months before implementation versus 6.6 months after implementation, 
p<0.002) 20.  It remains difficult to interpret the results of these studies given their 
diverse design and objectives, and the confounding variables involved in evolving 
cancer care. 
Therefore, it is perhaps more useful to evaluate whether MTB has an impact on 
clinical management decisions.  Several studies in the adult population have examined 
this question 21-24.  These studies demonstrated that review in a MTB resulted in 
changes in clinical management in anywhere from 20 to 60% of cases presented.  These 
changes included reinterpretation of radiologic findings, pathologic findings, staging, 
need for additional imaging or procedures, or treatment strategies.   
Before now, there have been no studies examining pediatric MTB, and its impact 
on clinical management of children with cancer.  The current weekly format for 
pediatric MTB at C.S. Mott Children’s Hospital was established in July of 2012.  The 
format includes a weekly meeting of pediatric health care professionals from many 
disciplines including radiology, pathology, radiation oncology, pediatric oncology, and 
pediatric surgical specialties.  Cases are initially referred to tumor board by the initial 
evaluating service and the cases to be discussed for the week are sent out to all 
attendees prior to the meeting.  During the meeting, a brief history of the patient is 
provided and the radiologic and pathologic findings are reviewed and discussed 
together.  The case is then open to discussion to all attendees and consensus 
recommendations are made and forwarded back to the admitting service. 
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This study is a review of the first 158 cases presented at the MTB between July 
2012 and April 2014.  Significantly, we found that review at MTB resulted in changes in 
management in 35 patients.  These changes were a result of differences in radiologic 
interpretation, pathologic interpretation, and evaluation by medical, radiation, and 
surgical oncologists.  Within these differences, the most frequent change was observed 
in radiologic interpretation (19%).  These differences may reflect the importance of 
clinical context, the importance of continuity of interpretation, and comparative review 
with previous imaging findings.   Also of note, in 12 cases, changes in radiologic 
interpretation resulted in a decrease in the level of suspicion of lesions. Direct 
discussion between the pediatric radiologist and the clinicians allowed for a more 
nuanced discussion of the level of suspicion for a given lesion compared to a written 
report. Additionally, familiarity between the clinical teams and the radiologists allowed 
improved communication that enhanced patient care. In the current study, this was 
exemplified by avoidance of potentially unnecessary and costly initiation of new 
therapies or procedures.  
Similarly, changes in pathologic interpretation at the MTB had a direct impact on 
clinical management.  Three patients had an upstaging of cancer based on pathology 
and four patients had a change in treatment plan, namely chemotherapy versus 
radiation versus surgical treatment. In the absence of changes in radiologic and 
pathologic interpretation, discussion and consensus opinion at the MTB resulted in 
changes in the clinical management of an additional 19 patients (12%). Though not 
measured in this report, such discussions also consistently led to consideration of 
referrals for fertility preservation, cancer genetic testing, and coordination of social 
services that had not been previously offered. 
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While review at MTB resulted in changes in management in nearly 1/3 of 
patients, there were many patients who did not have any changes but received 
confirmation of diagnostic tests and treatment plans. As this was a newly implemented 
tumor board, we did not turn away any patients and discussed each patient as 
requested. As the volume of patients discussed during MTB grows, mechanisms to 
screen patients to determine who will benefit the most from MTB review will be 
important.  
As a retrospective review, this study has limitations.  Recommendations from the 
tumor board were based on the best judgment of the tumor board physicians and 
specialists for each patient. Given this, it is occasionally difficult to determine the “gold 
standard” interpretation.  To address this in the weekly meetings, we requested and 
recommended that at least two to three specialists from each discipline be present and 
available for MTB discussion. On the rare occasion that this was not possible or in cases 
where a change in interpretation during MTB was significantly different than the 
original interpretation, we consulted with the original radiologist or pathologist, as well 
as an additional pediatric radiology or pathology subspecialist (outside of the MTB 
meeting) for consensus conclusions. Although the goal of the MTB is to adhere to 
established National Cancer Institute and Children’s Oncology Group guidelines, no 
internal controls were in place to ensure accuracy of this process, and therefore 
decisions were subject to some level of physician preference and opinion. In addition, 
although the MTB made recommendations, individual providers directly responsible for 
the patients may have pursued alternative treatment courses.  There is currently no 
mechanism in place to assess the accuracy of adoption of MTB recommendations. Many 
patients were presented several times during the course of treatment and this has 
allowed us to begin follow-up analysis of whether recommendations manifested into 
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treatment changes and impacted patient outcomes. This will be a future area of 
investigation. 
 In summary, this is the first review of the experience of pediatric MTB. Our study 
reveals that tumor board review can lead to recommendations for change in treatment 
in a significant number of patients, and provides additional perspectives for families 
and care providers when delineating optimal treatment plans. 
 
CONFLICT OF INTEREST STATEMENT: The authors declare no conflict of interests. 
 
ACKNOWLEDGEMENTS 
The authors thank the physicians, pediatric nurses and practitioners, physician 
assistants, administrative staff, trainees, and Katy Fasl, MSW of the Mott Solid Tumor 
Oncology Program for their tremendous dedication and efforts to weekly MTB at C.S. 
Mott Children’s Hospital. We also wish to thank Rebecca Priest for her efforts in helping 
us to make MTB and the Mott Solid Tumor Oncology Program available to children and 
families locally and regionally. 
 
References 
 
1. Wright FC, De Vito C, Langer B, Hunter A. Multidisciplinary cancer conferences: a 
systematic review and development of practice standards. Eur J Cancer. Apr 
2007;43(6):1002-1010. 
2. Petty JK, Vetto JT. Beyond doughnuts: tumor board recommendations influence 
patient care. J Cancer Educ. Summer 2002;17(2):97-100. 
3. Nyquist JG, Radecki SE, Gates JD, Abrahamson S. An educational intervention to 
improve hospital tumor conferences. J Cancer Educ. Summer 1995;10(2):71-77. 
4. Radecki SE, Nyquist JG, Gates JD, Abrahamson S, Henson DE. Educational 
characteristics of tumor conferences in teaching and non-teaching hospitals. J Cancer 
Educ. Winter 1995;9(4):204-216. 
5. Croke JM, El-Sayed S. Multidisciplinary management of cancer patients: chasing a 
shadow or real value? An overview of the literature. Curr Oncol. Aug 
2012;19(4):e232-238. 
  
 
This article is protected by copyright. All rights reserved. 
 
13 
6. Back MF, Ang EL, Ng WH, See SJ, Lim CC, Tay LL, Yeo TT. Improvements in 
quality of care resulting from a formal multidisciplinary tumour clinic in the 
management of high-grade glioma. Ann Acad Med Singapore. May 2007;36(5):347-
351. 
7. Expert Advisory Group on Cancer. A policy framework for commissioning cancer 
services: a report to the chief medical officers of England and Wales. The Calman–
Hine Report. Department of Health, London; 1995. 
8. "Cancer Program Standards (2016 Edition)." American College of Surgeons. 
https://http://www.facs.org/quality-programs/cancer/coc/standards. Accessed April 
26, 2016. 
9. Fleissig A, Jenkins V, Catt S, Fallowfield L. Multidisciplinary teams in cancer care: 
are they effective in the UK? Lancet Oncol. Nov 2006;7(11):935-943. 
10. Jalil R, Akhter W, Lamb BW, Taylor C, Harris J, Green JS, Sevdalis N. Validation of 
team performance assessment of multidisciplinary tumor boards. J Urol. Sep 
2014;192(3):891-898. 
11. Lamb BW, Green JS, Benn J, Brown KF, Vincent CA, Sevdalis N. Improving 
decision making in multidisciplinary tumor boards: prospective longitudinal 
evaluation of a multicomponent intervention for 1,421 patients. J Am Coll Surg. Sep 
2013;217(3):412-420. 
12. Lamb BW, Brown KF, Nagpal K, Vincent C, Green JS, Sevdalis N. Quality of care 
management decisions by multidisciplinary cancer teams: a systematic review. Ann 
Surg Oncol. Aug 2011;18(8):2116-2125. 
13. Blazeby JM, Wilson L, Metcalfe C, Nicklin J, English R, Donovan JL. Analysis of 
clinical decision-making in multi-disciplinary cancer teams. Ann Oncol. Mar 
2006;17(3):457-460. 
14. Leo F, Venissac N, Poudenx M, Otto J, Mouroux J. Multidisciplinary management of 
lung cancer: how to test its efficacy? J Thorac Oncol. Jan 2007;2(1):69-72. 
15. Tattersall MH. Multidisciplinary team meetings: where is the value? Lancet Oncol. 
Nov 2006;7(11):886-888. 
16. Stalfors J, Lundberg C, Westin T. Quality assessment of a multidisciplinary tumour 
meeting for patients with head and neck cancer. Acta Otolaryngol. Jan 
2007;127(1):82-87. 
17. Birchall M, Bailey D, King P. Effect of process standards on survival of patients with 
head and neck cancer in the south and west of England. Br J Cancer. Oct 18 
2004;91(8):1477-1481. 
18. Stephens MR, Lewis WG, Brewster AE, Lord I, Blackshaw GR, Hodzovic I, Thomas 
GV, Roberts SA, Crosby TD, Gent C, et al. Multidisciplinary team management is 
associated with improved outcomes after surgery for esophageal cancer. Dis 
Esophagus. 2006;19(3):164-171. 
19. Traynor BJ, Alexander M, Corr B, Frost E, Hardiman O. Effect of a multidisciplinary 
amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 
1996-2000. J Neurol Neurosurg Psychiatry. Sep 2003;74(9):1258-1261. 
20. Forrest LM, McMillan DC, McArdle CS, Dunlop DJ. An evaluation of the impact of a 
multidisciplinary team, in a single centre, on treatment and survival in patients with 
inoperable non-small-cell lung cancer. Br J Cancer. Oct 31 2005;93(9):977-978. 
21. Greer HO, Frederick PJ, Falls NM, Tapley EB, Samples KL, Kimball KJ, Kendrick 
JE, Conner MG, Novak L, Straughn JM, Jr. Impact of a weekly multidisciplinary 
tumor board conference on the management of women with gynecologic 
malignancies. Int J Gynecol Cancer. Nov 2010;20(8):1321-1325. 
  
 
This article is protected by copyright. All rights reserved. 
 
14 
22. Newman EA, Guest AB, Helvie MA, Roubidoux MA, Chang AE, Kleer CG, Diehl 
KM, Cimmino VM, Pierce L, Hayes D, et al. Changes in surgical management 
resulting from case review at a breast cancer multidisciplinary tumor board. Cancer. 
Nov 15 2006;107(10):2346-2351. 
23. Pawlik TM, Laheru D, Hruban RH, Coleman J, Wolfgang CL, Campbell K, Ali S, 
Fishman EK, Schulick RD, Herman JM, et al. Evaluating the impact of a single-day 
multidisciplinary clinic on the management of pancreatic cancer. Ann Surg Oncol. 
Aug 2008;15(8):2081-2088. 
24. Wheless SA, McKinney KA, Zanation AM. A prospective study of the clinical impact 
of a multidisciplinary head and neck tumor board. Otolaryngol Head Neck Surg. Nov 
2010;143(5):650-654. 
 
 
TABLE 1. Changes in Radiologic Interpretation and Management (n=158) 
 
Changes in Radiologic Interpretation No. % 
Additional lesions 3 1.9 
Increased or decreased suspicion of lesion 18 11 
Need for additional biopsy 2 1.2 
Need for additional imaging 5 3.1 
Different lesion marked for biopsy 2 1.2 
Total 30 18.4 
Changes in Management Based on Review of Radiology 
Observation 8 5 
Change in staging 1 0.6 
Change in lesion planned for biopsy 2 1.2 
Change in initial management from medical to surgical 1 0.6 
Total 12 7.6 
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TABLE 2. Changes in Pathologic Interpretation and Management (n=158) 
 
Change in Pathologic Interpretation No. % 
Change in pathologic diagnosis 3 1.9 
Change in pathologic staging 3 1.9 
Total 6 3.8 
Change in Management Based on Review of Pathology   
Initiate new therapy 2 1.2 
Change current therapy 1 0.6 
Require surgical management 1 0.6 
Total 4 2.5 
TABLE 3. Changes in Management Decisions Made During Tumor Board 
Review 
Change in Management Based on Oncology or Surgical Review No. % 
Initiation of new chemotherapy 2 1.2 
Continuation of current chemotherapy regimen 3 1.9 
Cessation of chemotherapy 1 1.2 
Referral for surgical management 2 1.9 
Recommend additional procedures prior to surgery 3 1.9 
Confirm operative plan 4 2.5 
Change operative plan 2 1.9 
No longer recommend surgical management 2 1.9 
Total 19 14.4 
 
 
